000130366 001__ 130366
000130366 005__ 20240124152851.0
000130366 0247_ $$2doi$$a10.1097/TP.0000000000001399
000130366 0248_ $$2sideral$$a96606
000130366 037__ $$aART-2016-96606
000130366 041__ $$aeng
000130366 100__ $$aAlvarez-Sotomayor, D.
000130366 245__ $$aControlling Diabetes after Liver Transplantation: Room for Improvement
000130366 260__ $$c2016
000130366 5203_ $$aBackground Diabetes mellitus is a chronic illness with great impact on long-term outcome after liver transplantation (LT). Despite this, the current level of glycemic control and quality of screening strategies for diabetes-associated conditions that are being provided to liver transplant recipients with diabetes have not yet been assessed. Methods We performed a cross-sectional, multicenter study that included 344 liver transplant recipients and examined the level of glycemic control and its associated factors, as well as the quality of screening strategies for diabetes-associated conditions. Results Seventy-five patients (21.8%) suffered from diabetes before transplantation, and 82 (23.8%) developed diabetes mellitus after transplantation. Adequate glycemic control (HbA1c < 7%) was achieved in 66.7% of the patients. Forty-eight percent of patients underwent regular screening for retinopathy, 47.1% for nephropathy, 4.5% for neuropathy, and 5.7% for foot ulcers. Diabetes was associated with higher frequency of cardiovascular disease and dyslipidemia both before and after LT. Multivariate analysis revealed association between poor glycemic control and arterial hypertension, presence of diabetes before transplantation, elevated GGT, and insulin use. Conclusions Glycemic control was inadequate in 33.3% of LT recipients with diabetes, and screening protocols for diabetes-associated conditions did not meet the standards for medical care set by the American Diabetes Association in any of the participating centers. Consequently, this study reveals a clear deficiency in the quality of diabetes care provided to patients after LT and, hence, we predict that future progress in this area will have a significant impact on medium-term to long-term outcome of these patients. Copyright
000130366 540__ $$9info:eu-repo/semantics/openAccess$$aAll rights reserved$$uhttp://www.europeana.eu/rights/rr-f/
000130366 590__ $$a3.678$$b2016
000130366 591__ $$aSURGERY$$b28 / 195 = 0.144$$c2016$$dQ1$$eT1
000130366 591__ $$aTRANSPLANTATION$$b8 / 25 = 0.32$$c2016$$dQ2$$eT1
000130366 591__ $$aIMMUNOLOGY$$b54 / 149 = 0.362$$c2016$$dQ2$$eT2
000130366 592__ $$a1.544$$b2016
000130366 593__ $$aTransplantation$$c2016$$dQ1
000130366 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000130366 700__ $$aSatorres, C.
000130366 700__ $$aRodríguez-Medina, B.
000130366 700__ $$aHerrero, I.
000130366 700__ $$ade la Mata, M.
000130366 700__ $$0(orcid)0000-0002-7119-2244$$aSerrano, T.$$uUniversidad de Zaragoza
000130366 700__ $$aRodríguez-Perálvarez, M.
000130366 700__ $$aD''Avola, D.
000130366 700__ $$aLorente, S.
000130366 700__ $$aRubín, A.
000130366 700__ $$aBerenguer, M.
000130366 7102_ $$11007$$2610$$aUniversidad de Zaragoza$$bDpto. Medicina, Psiqu. y Derm.$$cArea Medicina
000130366 773__ $$g100, 10 (2016), e66-e73$$pTransplantation$$tTransplantation$$x0041-1337
000130366 8564_ $$s187697$$uhttps://zaguan.unizar.es/record/130366/files/texto_completo.pdf$$yVersión publicada
000130366 8564_ $$s3381458$$uhttps://zaguan.unizar.es/record/130366/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000130366 909CO $$ooai:zaguan.unizar.es:130366$$particulos$$pdriver
000130366 951__ $$a2024-01-24-15:05:47
000130366 980__ $$aARTICLE